Standout Papers
Immediate Impact
2 from Science/Nature 61 standout
Citing Papers
Artificial intelligence in drug development
2025 Standout
Self-Cascaded Pyroptosis-STING Initiators for Catalytic Metalloimmunotherapy
2025 Standout
Works of Xuan Wang being referenced
A phase 2 clinical trial of neoadjuvant anti-PD-1 ab (Toripalimab) plus axitinib in resectable mucosal melanoma.
2021
Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis
2020 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Xuan Wang | 409 | 1014 | 640 | 143 | 2.1k | |
| Hiroyuki Matsuno | 277 | 1239 | 440 | 131 | 2.7k | |
| Xiaoguang Liu | 226 | 1052 | 406 | 112 | 2.3k | |
| Lina Sun | 255 | 1046 | 608 | 93 | 2.2k | |
| Ying Zhou | 216 | 1088 | 382 | 84 | 2.2k | |
| Ying Zhang | 254 | 1027 | 485 | 126 | 2.8k | |
| Yan Lü | 226 | 1191 | 420 | 146 | 2.5k | |
| Hyun Ju Yoo | 346 | 1133 | 295 | 108 | 2.4k | |
| Jian Wu | 350 | 1439 | 527 | 116 | 2.9k | |
| Keshen Li | 700 | 1159 | 510 | 110 | 2.4k | |
| Yong Cui | 194 | 1213 | 513 | 134 | 2.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...